CLI Ventures

CLI Ventures typically invests at early to late stages of companies in the U.S. and China.

CLI Ventures is a leading global venture capital and private equity investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare and data analytics companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel diagnostics, therapeutics, and data applications.​ With $1 billion under management and offices in Palo Alto, New York, Boston, San Diego, Los Angeles, Beijing, Shanghai, Shenzhen, and Wuhan. CLI has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. CLI affiliated funds have been involved in the formation of more than 200 portfolio companies. Our companies have created a number of U.S. and China approved products that have advanced human health. ​ CLI has developed innovative investment models, such as U.S.-China cross-border licensing, which have proven successful and have been widely emulated in the life science industry. CLI is engaged in new collaborations, including CLI’s investments in China with the health ministries and departments and local government at city and province levels, respectively.